Sign up now for the virtual SOSV Climate Tech Summit (Oct. 25-26)

SOSV Key Trends

Portfolio Companies

Reset All Filters                
Key Trends
Programs
Stage
Category
Region
Location
Aanika

Aanika Bio (fka Carverr)

Aanika Bio leverages synthetic biology to build a suite of solutions that can trace and authenticate various products in the supply chain.

Locations: United States

Achiko

Achiko has created user-friendly diagnostic testing integrated with a digital passport solution for the management of COVID-19. AptameX™ includes DNA aptamer-based technology that is cost effective, chemically synthesised, and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat™, Achiko is developing potential technologies that seek to […]

Locations: Indonesia

Aluna Medical Diagnostics

Aluna is a portable spirometer with a mobile interface that objectively tracks asthma severity to allow for a personalized and real-time action plan. Aluna automatically tracks your FEV1% over time. You can also monitor your symptoms, medication, exercise, and environmental factors. With the Aluna app, you can easily share your lung health data with your […]

Locations: United States

Avidbots

Avidbots is a startup dedicated to disrupting the commercial floor cleaning market with autonomous robotics. Avidbot’s sweeping and scrubbing robots cooperate to clean department stores, auto dealerships, education facilities, airports, and many other facilities. These robots automate the most labor- and time-intensive part of commercial cleaning.

Locations: Canada

CASPR Biotech

Caspr.bio has a COVID-19 test leveraging the CRISPR Cas-12 enzyme that is cheap and rapid, at point of care. The San Francisco and Buenos Aires-based company started 2 years ago, went through IndieBio, and originally worked on Zika virus and other genetic testing. Caspr’s methodology delivers positive tests results very quickly after RNA extraction (1 […]

Locations: United States

Circadia

Circadia enables the early detection of respiratory complications, the third leading cause of death, to save patient lives. The company provides an inexpensive, medical-grade, frictionless solution to clinicians in order to help improve patient outcomes, reduce provider workload and reduce the cost of care. Circadia’s C100 Contactless Respiratory Monitoring System conveniently monitors patients with acute […]

Locations: United Kingdom

DARMA

Darma is the world’s first “inactivity tracker”—a non-invasive smart cushion to monitor your sitting habits and improve your physical and mental health. Darma uses novel sensor technology and algorithms to offer actionable guidance to improve posture, balance sitting time, and reduce stress. Darma learns your sitting habits to present you with actionable coaching, from stand […]

Locations: United States

Diadem Biotherapeutics

Diadem is engineering exosomes to be inhalable cell-specific immune modulators. Exosomes are small, virus-sized particles released by cells to communicate throughout the body. Diadem plans to develop a SARS-CoV-2 vaccine by engineering exosomes with surface bound SARS-CoV-2 proteins and immune-stimulating ligands, effectively turning them into non-replicative virus-like particles (VLP). To increase immune response and memory […]

Locations: United States

No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the “Materials”), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.